Table 4.
Comparison of outcome measurement between the control and intervention groups.
| Measure | Difference in T1a (95%CI) | Z value | P valueb | |
| MUSEc |
|
|
|
|
|
|
All medications | 2.74 (1.29-4.19) | –3.14 | .002 |
|
|
Hypertensived | 2.35 (0.87-3.81) | –2.65 | .008 |
|
|
Antithrombotice | 2.78 (1.28-4.29) | –3.14 | .002 |
| Systolic blood pressured (mmHg) | 0.96 (–6.58-8.49) | –0.17 | .86 | |
| Diastolic blood pressured (mmHg) | 6.04 (0.94-11.14) | –1.84 | .07 | |
aT1: mean score/measurement differences between intervention and control groups at 3 months postrandomization.
bMann-Whitney U test.
cMUSE: medication understanding and use self-efficacy.
dPrescribed with antihypertensive medication and diagnosed with hypertension as a primary factor (control group n=24, intervention group n=26).
ePrescribed antithrombotic as a prerequisite preventative treatment for stroke (control group n=27, intervention group n=27).